نتائج البحث

Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.

• Authors : Makkeyah SM; Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Elseedawy ME

Subjects: Hemangioma*/Hemangioma*/Hemangioma*/drug therapy ; Propranolol*/Propranolol*/Propranolol*/therapeutic use ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/blood

• Source: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2022 Apr; Vol. 39 (3), pp. 215-224. Date of Electronic Publication: 2021 Sep 03.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma.

• Authors : Farshchian M; Department of Dermatology, Wayne State University, Detroit, Michigan, USA.; Potts GA

Subjects: Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/*adverse effects ; Hemangioma/Hemangioma/Hemangioma/*drug therapy ; Hypertriglyceridemia/Hypertriglyceridemia/Hypertriglyceridemia/*chemically induced

• Source: The Australasian journal of dermatology [Australas J Dermatol] 2021 Nov; Vol. 62 (4), pp. e580-e581. Date of Electronic Publication: 2021 Jul 22.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effect of Oral Propranolol on Periocular Infantile Capillary Hemangioma: Outcomes Based on Extent of Involvement.

• Authors : Bejjanki KM; Ocular Oncology Serices, The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.; Akhtar K

Subjects: Adrenergic beta-Antagonists*/Adrenergic beta-Antagonists*/Adrenergic beta-Antagonists*/therapeutic use ; Hemangioma, Capillary*/Hemangioma, Capillary*/Hemangioma, Capillary*/drug therapy ; Propranolol*/Propranolol*/Propranolol*/therapeutic use

• Source: Middle East African journal of ophthalmology [Middle East Afr J Ophthalmol] 2021 Apr 30; Vol. 28 (1), pp. 6-10. Date of Electronic Publication: 2021 Apr 30 (Print Publication: Publisher: Medknow Publications and Media Country of Publication: India NLM ID: 101521797 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

Klebsiella pneumoniae‐infected hemorrhagic ulcerative infantile hemangioma: A rare complication.

• Authors : Abtahi‐Naeini, Bahareh^1,2 (AUTHOR); Pourmahdi‐Boroujeni, Mahsa³ (AUTHOR); Alipour, Narjes⁴ (AUTHOR)

• Source: Clinical Case Reports. Jul2024, Vol. 12 Issue 7, p1-7. 7p.

تفاصيل العنوان

Successful treatment of infantile hemangioma with high risk of severe sequelae by microneedle radiofrequency.

• Authors : Qiu Y; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Qiao C

Subjects: Hemangioma* ; Propranolol*; Disease Progression

• Source: Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e13953. Date of Electronic Publication: 2020 Aug 11.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

To study the role of propranolol in infantile hemangioma: A prospective randomized study.

• Authors : B. M. S., Pokhariya¹ ; Tiwari, Supriya²; Gogia, Bhupesh³

• Source: Asian Journal of Medical Sciences. Jun2024, Vol. 15 Issue 6, p136-140. 5p.

تفاصيل العنوان

Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma.

• Authors : Wang L; Department of Radiology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, China.; Zheng K

Subjects: Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*genetics ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*metabolism ; Hemangioma/Hemangioma/Hemangioma/*drug therapy

• Source: BioMed research international [Biomed Res Int] 2020 Mar 07; Vol. 2020, pp. 8732871. Date of Electronic Publication: 2020 Mar 07 (Print Publication: 2020).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

Change of serum cytokine profiles by propranolol treatment in patients with infantile hemangioma.

• Authors : Tani S; Department of Dermatology, Wakayama Medical University, Wakayama, Japan.; Kunimoto K

Subjects: Cytokines/Cytokines/Cytokines/*blood ; Hemangioma/Hemangioma/Hemangioma/*drug therapy ; Propranolol/Propranolol/Propranolol/*therapeutic use

• Source: Drug discoveries & therapeutics [Drug Discov Ther] 2020; Vol. 14 (2), pp. 89-92.Publisher: Shandong University China-Japan Cooperation Center for Drug Discovery & Screen Country of Publication: Japan NLM ID: 101493809 Publication Model:

تفاصيل العنوان

Retrospective Evaluation of an Oral Propranolol Delivery Strategy in 25 Cases of Infantile Hemangioma

• Authors : Shinichi Ashizawa; Takanobu Kan; Shunsuke Takahagi

Subjects: infantile hemangioma; propranolol; sequelae

• Source: Journal of Plastic and Reconstructive Surgery, Vol 3, Iss 2, Pp 94-98 (2024)

تفاصيل العنوان

Role of Propranolol as Compared to Bleomycin in Management of Hemangioma

• Authors : Ali Raza Chaudhry, Senior Registrar as principal investigator

• Source: Thayal PK, Bhandari PS, Sarin YK. Comparison of efficacy of intralesional bleomycin and oral propanolol in management of hemangiomas. Plast Reconstr Surg. 2012 Apr;129(4):733e-735e. doi:

تفاصيل العنوان